Hematological indices: potential markers of disease activity in ankylosing spondylitis patients treated with biological drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Hematological indices: potential markers of disease activity in ankylosing spondylitis patients treated with biological drugs ; volume:36 ; number:1 ; day:29 ; month:7 ; year:2024 ; pages:1-9 ; date:12.2024
The Egyptian Journal of Internal Medicine ; 36, Heft 1 (29.7.2024), 1-9, 12.2024
- Creator
-
Ibrahim, Amira M.
El-Nahal, Ayat S.
Ahmed, Hebatalla A.
Youssif, Zeinab A.
Abdelsalam, Mahmoud A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43162-024-00337-1
- URN
-
urn:nbn:de:101:1-2410132121540.235721189338
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ibrahim, Amira M.
- El-Nahal, Ayat S.
- Ahmed, Hebatalla A.
- Youssif, Zeinab A.
- Abdelsalam, Mahmoud A.
- SpringerLink (Online service)
Other Objects (12)
Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis
Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Development of early diagnostic systems for ankylosing spondylitis
Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
Andersson lesion in ankylosing spondylitis
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
ANKHvariants associated with ankylosing spondylitis: gender differences
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Association between ankylosing spondylitis and m6A methylation
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis